Logo image
Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections
Journal article   Peer reviewed

Safe Staphylococcal Platform for the Development of Multivalent Nanoscale Vesicles against Viral Infections

Jizhen Yuan, Jie Yang, Zhen Hu, Yi Yang, Weilong Shang, Qiwen Hu, Ying Zheng, Huagang Peng, Xiaopeng Zhang, Xinyu Cai, …
Nano letters, Vol.18(2), pp.725-733
14/02/2018
PMID: 29253342

Abstract

Animals Bacterial Proteins - genetics Cell-Derived Microparticles - genetics Dengue - prevention & control Dengue Vaccines - administration & dosage Dengue Vaccines - genetics Dengue Vaccines - therapeutic use Dengue Virus - genetics Gene Deletion Humans Mice Mice, Inbred BALB C Recombinant Fusion Proteins - genetics Staphylococcus aureus - genetics Trans-Activators - genetics Viral Envelope Proteins - genetics
Many viruses often have closely related yet antigenically distinct serotypes. An ideal vaccine against viral infections should induce a multivalent and protective immune response against all serotypes. Inspired by bacterial membrane vesicles (MVs) that carry different protein components, we constructed an agr locus deletion mutant of the Staphylococcus aureus strain (RN4220-Δagr) to reduce potential toxicity. Nanoscale vesicles derived from this strain ( MVs) carry at least four major components that can deliver heterologous antigens. These components were each fused with a triple FLAG tag, and the tagged proteins could be incorporated into the MVs. The presentation levels were (3.43 ± 0.73)%, (5.07 ± 0.82)%, (2.64 ± 0.61)%, and (2.89 ± 0.74)% of the total MV proteins for Mntc-FLAG, PdhB-FLAG, PdhA-FLAG, and Eno-FLAG, respectively. With two DENV envelope E domain III proteins (EDIIIconA and EDIIIconB) as models, the DENV EDIIIconA and EDIIIconB delivered by two staphylococcal components were stably embedded in the MVs. Administration of such engineered MVs in mice induced antibodies against all four DENV serotypes. Sera from immunized mice protected Vero cells and suckling mice from a lethal challenge of DENV-2. This study will open up new insights into the preparation of multivalent nanosized viral vaccines against viral infections.

Metrics

1 Record Views

Details

Logo image